Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GoodSense NightTime Cold & Flu Multi Symptom is an over-the-counter (OTC) combination medication developed by Perrigo under the GoodSense brand. It is formulated to provide temporary relief from multiple symptoms associated with the common cold and influenza, specifically designed for nighttime use. The product contains three active ingredients: acetaminophen, which acts as an analgesic and antipyretic to reduce pain and fever; dextromethorphan hydrobromide, an antitussive that suppresses the cough reflex; and doxylamine succinate, a sedating antihistamine that relieves runny nose and sneezing while facilitating sleep. As a generic equivalent to brand-name products like NyQuil, it is widely used for managing nocturnal respiratory tract symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetaminophen + dextromethorphan hydrobromide + doxylamine succinate.